[July 29, 2016] |
|
World Alpha-Amylase Inhibitors Pipeline Insights 2016 - Research and Markets
Research and Markets has announced the addition of the "Alpha-Amylase
Inhibitors -Pipeline Insights, 2016" report to their offering.
Alpha-Amylase Inhibitors-Pipeline Insights, 2016 provides in depth
insights on the pipeline drugs and their development activities around
the Alpha-Amylase Inhibitors. The report covers the product profiles in
various stages of development including Discovery, Pre-clinical, IND,
Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Alpha-Amylase
Inhibitors.
The report also assesses the Alpha-Amylase Inhibitors therapeutics by
Monotherapy, Combination products, molecule type and Route of
Administration.
Scope
-
The report provides competitive pipeline lanscape of Alpha-Amylase
Inhibitors
-
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the Alpha-Amylase Inhibitors pipeline on the basis of
target, MOA, route of administration, technology involved and molecule
type
-
The report reviews key players involved in the therapeutics
development for Alpha-Amylase Inhibitors and also provide company
profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/ttkwsp/alphaamylase
View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005665/en/
[ Back To TMCnet.com's Homepage ]
|